GemVax&KAEL Co.Ltd
GemVax&KAEL Co.,Ltd engages in the manufacturing and commercializing of resins and filters for semi-conductor and panel display production in South Korea. The company offers impregnated active carbon and inorganic adsorbent coating resins; CA filter for removing chemical pollution substances and harmful gases in semiconductor and LCD/PDP manufacturing process; adsorbent towers for air pollution p… Read more
GemVax&KAEL Co.Ltd (082270) - Total Liabilities
Latest total liabilities as of September 2025: ₩107.37 Billion KRW
Based on the latest financial reports, GemVax&KAEL Co.Ltd (082270) has total liabilities worth ₩107.37 Billion KRW as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
GemVax&KAEL Co.Ltd - Total Liabilities Trend (2010–2024)
This chart illustrates how GemVax&KAEL Co.Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
GemVax&KAEL Co.Ltd Competitors by Total Liabilities
The table below lists competitors of GemVax&KAEL Co.Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Viglacera Corp JSC
VN:VGC
|
Vietnam | ₫14.87 Trillion |
|
Lovisa Holdings Ltd
AU:LOV
|
Australia | AU$619.88 Million |
|
Kiatnakin Bank Public Company. Ltd
OTCGREY:KNFSF
|
USA | $422.89 Billion |
|
MannKind Corp
NASDAQ:MNKD
|
USA | $539.19 Million |
|
Tianneng Battery Group Co Ltd
SHG:688819
|
China | CN¥27.99 Billion |
|
Bic Camera Inc
F:1U3
|
Germany | €280.77 Billion |
|
Xiamen Meiya Pico Information
SHE:300188
|
China | CN¥1.79 Billion |
|
Apollo Medical Holdings Inc
F:3AM
|
Germany | €1.68 Billion |
Liability Composition Analysis (2010–2024)
This chart breaks down GemVax&KAEL Co.Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.51 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 2.13 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.68 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how GemVax&KAEL Co.Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for GemVax&KAEL Co.Ltd (2010–2024)
The table below shows the annual total liabilities of GemVax&KAEL Co.Ltd from 2010 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | ₩121.74 Billion | +348.65% |
| 2023-12-31 | ₩27.13 Billion | +61.60% |
| 2022-12-31 | ₩16.79 Billion | -8.50% |
| 2021-12-31 | ₩18.35 Billion | -22.22% |
| 2020-12-31 | ₩23.59 Billion | -65.42% |
| 2019-12-31 | ₩68.23 Billion | +16.07% |
| 2018-12-31 | ₩58.78 Billion | -37.27% |
| 2017-12-31 | ₩93.71 Billion | -31.22% |
| 2016-12-31 | ₩136.25 Billion | +2.81% |
| 2015-12-31 | ₩132.53 Billion | +112.55% |
| 2014-12-31 | ₩62.35 Billion | -20.50% |
| 2013-12-31 | ₩78.43 Billion | +9.38% |
| 2012-12-31 | ₩71.70 Billion | +24.38% |
| 2011-12-31 | ₩57.65 Billion | +226.40% |
| 2010-12-31 | ₩17.66 Billion | -- |